This inventor holds 7 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 5 EPO patents. Top assignees: Wyeth, Wyeth Holdings Corporation, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2004-2014.
Company Filing History:
3 out of 1,309 
3 out of 113 
1 out of 3,688 
Years Active: 2004-2014
Title: The Innovations of Stephen Alexander Udem
Introduction
Stephen Alexander Udem is a notable inventor based in New York, NY, with a significant contribution to the field of virology. He holds a total of seven patents, showcasing his innovative approach to scientific challenges. His work primarily focuses on the attenuation of viruses, which has important implications for vaccine development and infectious disease management.
Latest Patents
Among his latest patents is the invention titled "Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof." This invention broadly relates to the synergistic attenuation of vesicular stomatitis virus (VSV). More particularly, it involves the identification of combined mutation classes that synergistically reduce the pathogenicity of VSV vectors in mammals and the development of immunogenic compositions based on these findings.
Career Highlights
Throughout his career, Udem has worked with prominent companies in the pharmaceutical industry, including Wyeth Holdings Corporation and Wyeth. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in medical science.
Collaborations
Udem has collaborated with several professionals in his field, including Christopher Lee Parks and David Kirkwood Clarke. These collaborations have likely enriched his research and contributed to the success of his inventions.
Conclusion
Stephen Alexander Udem's contributions to the field of virology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of effective viral therapies and vaccines.